SS 35 - CNS 3: Spine, Benign, and FLASH: Oh my!

Presentations

• 12:45pm - 12:55pm PT

  Radiation Therapy Alone vs. Radiation Therapy Plus Radiofrequency Ablation/Vertebral Augmentation for Painful Spine Metastasis: A Randomized Controlled Trial

  Speaker: Rupesh Kotecha, MD - Miami Cancer Institute, Miami
• 12:55pm - 01:05pm PT

  Dose Escalated vs. Standard Dose Post Operative Radiation Therapy for High Risk Meningiomas: An International Individual Patient Level Meta-Analysis (FIRESTORM)

  Speaker: Raj Singh, MD - The Ohio State University Wexner Medical Center, Columbus
• 01:05pm - 01:15pm PT

  Elective Target Stereotactic Spine Radiosurgery (SSRS) Reduces Risk of Long-Term Treatment Failure Compared to Involved Target SSRS: Final Analysis of A Prospective Randomized Phase II Trial

  Speaker: Feng-Ming Hsu, MD, PhD - National Taiwan University Cancer Center, Taipei
• 01:15pm - 01:25pm PT

  Impact of Castrate Sensitivity and Genetic Mutations on Local Control after Spine Stereotactic Body Radiation Therapy for Prostate Cancer Spinal Metastases

  Speaker: Christopher Jackson, MD, MS - Memorial Sloan Kettering Cancer Center, New York
• 01:25pm - 01:35pm PT

  Genomic Mutation-Driven Stratification of Treatment Response to Stereotactic Spine Radiosurgery in Spinal Metastases

  Speaker: Areeba Al-Sharfeen, BS - MD Anderson Cancer Center, Houston
• 01:35pm - 01:45pm PT

  Temporal Effects of Dose and Fractionation of FLASH and Conventional Irradiation on Hippocampal Neurogenesis and Mechanisms of FLASH-Induced Neuroprotection

  Speaker: Nikita Katila, PhD - Stanford School of Medicine, Stanford
• 01:45pm - 01:55pm PT

  Discussant

  Speaker: William Breen, MD - Mayo Clinic Rochester, Rochester